Related Experiment Videos
Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications
1Department of Anaesthesiology, University Hospital Lausanne, Switzerland.
British Journal of Anaesthesia
|October 16, 2004
Summary
Transfusion medicine decisions require careful risk-benefit analysis, especially regarding red blood cell (RBC) transfusion thresholds and patient outcomes. This review provides guidelines and discusses alternatives to minimize patient risk.
Area of Science:
- Transfusion Medicine
- Hematology
- Clinical Practice Guidelines
Background:
- Allogeneic red blood cell (RBC) transfusion decisions necessitate a thorough risk-benefit assessment.
- Key controversies in transfusion medicine include the impact of varying transfusion thresholds on clinical outcomes.
Purpose of the Study:
- To review current evidence on blood transfusions.
- To highlight critical issues concerning transfusion efficacy, patient outcomes, and associated risks.
- To offer evidence-based transfusion guidelines and discuss alternatives.
Main Methods:
- Literature review of current evidence on blood transfusions.
- Analysis of 'hot topics' in transfusion medicine.
- Synopsis of transfusion alternatives.
Main Results:
- Evidence suggests varying transfusion thresholds significantly influence clinical outcomes.
- Identification of key areas of controversy and risk in transfusion practice.
- Development of practical transfusion guidelines.
Conclusions:
- Physicians can optimize transfusion decisions by integrating current evidence with clinical expertise.
- Informed decisions based on risk-benefit analysis and guidelines minimize patient risk.
- Consideration of transfusion alternatives is crucial for patient care.